Pfizer Inc.

Stocks

Market Closed - NYSE 04:01:33 2026-08-31 pm EDT			Pre-market 08:39:20 am
28.46 ^USD	+1.79%		28.62	+0.54%

07:51am	Global pharma companies that have publicly announced Trump drug pricing agreements	RE
02:40am	GSK Moves mRNA Flu Vaccine Candidate to Late-Stage Trial	DJ

Published on 06/17/2026 at 03:37 pm EDT

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Good day everyone and welcome to Pfizer Flash Live from ADA, spotlighting berobenatide, an investigational potential first-in-class monthly GLP-1

This article is reserved for our subscribers.

To unlock the article,
subscribe!

Unlimited browsing across the entire site

Access to all news and data

US, Europe, and Asia portfolios

Ad-free reading

Pro Tools : expert screeners, historical financials, PDF reports, investment themes, and earnings transcripts

07:51am	Global pharma companies that have publicly announced Trump drug pricing agreements	RE
02:40am	GSK Moves mRNA Flu Vaccine Candidate to Late-Stage Trial	DJ
Aug. 31	Trump announces new round of drug-pricing deals	RE
Aug. 31	Donald Trump prepares new agreements to reduce drug prices
Aug. 31	Trump administration to announce drug pricing deals	RE
Aug. 28	BioNTech Terminates Phase 2 Colorectal Cancer Clinical Trial; Shares Fall	MT
Aug. 28	FDA Approves Seasonal Covid-19 Vaccines From Moderna, Pfizer, BioNTech, Novavax -- Update	DJ
Aug. 28	Global markets live: Nvidia, Marvell, Rivian, Eli Lilly, Moderna…
Aug. 28	Roivant, Priovant launch newly approved rare disease drug Lisraya at $35,000 a month	RE
Aug. 28	Warsh Takes the Stage
Aug. 28	A tale of two markets
Aug. 27	FDA Approves Seasonal Covid-19 Vaccines From Moderna, Pfizer, BioNTech	DJ
Aug. 27	Pfizer, BioNTech Get US FDA Clearance for COVID-19 Vaccine Targeting XFG Variant	MT
Aug. 27	Pfizer And BioNTech Receive U.S. FDA Approval For XFG-Adapted COVID-19 Vaccine	CI
Aug. 27	US FDA approves Roivant-Priovant's skin and muscle disease drug	RE